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1. Introduction
   Frankincense is the gum resin obtained by the incisions 
in the trunk of the trees of Boswellia genus, belonging 
to the family Burseraceae. Boswellia sacra (B. sacra) 
Flueckiger is native to Oman; a closely related specie (B. 
carteri) growing also in Yemen and Northern Somalia[1]. 
In Dhofar (Southern Oman), the frankincense of B. carteri 
was made into an ointment to treat severe muscle pain. 
There are several other remedies made from frankincense 
used in Oman including “Luban Dhakar” which is used 
for treatment of cold, cough and fever. This is probably 
due to the analgesic effects of frankincense[2,3]. In Oman, 
B. sacra gum extracts are utilized traditionally in various 
folk medicines for strengthening the teeth and gum, for 
stimulating the digestion process, to combat halitosis and 
in many more health problems, including inflammatory 
disorders and cancer[4,5]. In Dhofar (Southern Oman), the 
frankincense resin is soaked in water overnight and taken 
ARTICLE INFO                           ABSTRACT
Objective: To investigate the analgesic effect of Boswellia sacra (B. sacra), which could support 
the Omani traditional uses of frankincense for muscle, stomach, and arthritis pain. 
Methods: The crude extract, the essential oils and various sub-fractions of the crude methanol 
extract (each 300 mg/kg of the body weight of the animal) obtained from the resin of B. sacra were 
administered orally, and were evaluated for their analgesic activities by using two well known 
models of pain in mice, viz. acetic acid induced writhing test and formalin induced pain test in 
mice. 
Results: Of 13 samples, almost all of them were effective at an orally administered dose of 300 mg/
kg of the body weight. The acetic acid induced writhes were inhibited in all the three phases with 
comparable values to the standard drug aspirin (300 mg/kg of body weight) with inhibition of 67.6% 
in phase I, 66.8% in phase II, and 37.9% in phase III. At the same time, all the tested samples were 
found effective in both the early and the late phases of formalin test. In formalin test, most of the 
tested samples showed more inhibitory effects as compared to the standard drug aspirin (300 mg/
kg of body weight), which showed 36.2% and 29.6% inhibition in early and late phases respectively. 
Among the tested samples, the most significant inhibition was produced by Shabi frankincense 
oil (57.5% in early phase, and 55.6% in late phase). Interestingly, the extracts showed comparable 
percentage of inhibition to the oil and found in the following order: 60% chloroform/n-hexane 
sub-fraction (55.3% in early phase, and 66.7% in late phase), and 70% chloroform/n-hexane sub-
fraction (59.6% in early phase, and 63.0% in late phase). 
Conclusions: The present study provided the scientific justification about the analgesic 
properties of the essential oils, extract, and various sub-fractions obtained from the resin of 
B. sacra, thus validating its use in traditional folk medicines and other products; and hence 
supporting the development in the analgesic properties of bioactive natural substances. 
 Contents lists available at ScienceDirect
Article history:
Received 26 Mar 2014
Received in revised form 17 Apr 2014
Accepted 12 May 2014
Available online 25 Jul 2014
Keywords:
Frankincense
Essential oil
Boswellia sacra
Analgesic activity
Nociception 
Ahmed Al-Harrasi et al./Asian Pac J Trop Med 2014; 7(Suppl 1): S485-S490S486
for 1 week for relief of the joint pain of arthritis. Buds and 
fruit provided a cleansing tonic for the digestive system. 
Brewed into a decoction with cinnamon and cardamom, 
the resin was used to treat stomach aches[2,3]. Burnt as 
incense, it was not only thought to keep off the demons 
of disease and reduce pain, but also thought to act as an 
expectorant and was used to clear phlegm from the head 
and chest in cases of colds, flu and conditions of the upper 
respiratory tract[2,3]. The gum resin extracts of various 
Boswellia species have been employed in traditional 
folk medicines for centuries, and the pharmacological 
potential of these extracts has also been confirmed by 
various animal model studies and the clinical studies 
on humans[6-9]. Boswellic acid and its derivatives are 
the pentacyclic triterpenoids which were reported to be 
isolated from the various species of the genus Boswellia. 
These boswellic acid derivatives are used for a variety 
of inflammatory disorders, such as rheumatoid arthritis, 
osteoarthritis, and cervical spondylosis, and are identified 
as inhibitors of various 5-lipoxigenases and human 
leukocyte elastase[10,11]. Recently, Sharma et al. has 
reported the anti-inflammatory and analgesic activities on 
the extract and the sub-fractions of Boswellia serrata[12]. 
However, to the best of our knowledge, no study has tested 
the traditional claim of the analgesic activity of B. sacra. 
Thus, the present study has been carried out on the crude 
methanol extract, essential oils, and the sub-fractions of 
the resin obtained from this plant in order to investigate 
the analgesic properties of this precious resin. In addition, 
the results of this study would also give an idea about the 
presence of boswellic acid derivatives in the resin of this 
unexplored plant of the genus Boswellia. 
2. Materials and methods
2.1. Plant material
   The aerial parts of B. sacra and the various grades 
of resin were collected in April and May 2010 from the 
different locations in Dhofar and were supplied by a 
trustful Dhofari partner (Dr. Saleh Al-Amri). Super 
hougari green (SHG), hougari regular (HR), royal hougari 
white (RHW), and hougari yellow (HY) grade resins were 
collected from Wadi Hougar, while Shabi frankincense (SF) 
was collected from Wadi Magsyl. All these samples were 
authenticated by Dr. Mustafa Mansi (botanist), Department 
of Biological Sciences and Chemistry, University of Nizwa, 
the Sultanate of Oman, and a voucher specimen (No. 
BSHR-01/2012) of the plant was deposited in the herbarium 
of the department.
2.2. Extraction and isolation
   The air-dried ground material of HR grade resin (500 g) 
was exhaustively extracted with 100% methanol at room 
temperature. The extract was evaporated to yield the 
residue (253 g). The methanol extract (100 g) was subjected 
to column chromatography over a silica gel column 
(1 000 g, 70-230 mesh, Merck) by using vacuum liquid 
chromatography and pure n-hexane as a solvent mobile 
phase. The polarity of the eluting solvent was increased 
with 5% chloroform gradient in polarity up to 100%, then 
with 1% gradient of methanol up to 10%, followed by the 
methanol gradients (15%, 20%, and 40% consecutively).
   Soxhlet apparatus was used to extract the oils of the 
various grades of the resin by using n-hexane as a solvent. 
This oil extraction was carried out by the standard method 
of Association of Official Analytical Communities[13]. Prior 
to the oil extraction, all the resin samples were kept under 
subdued light for drying, and the dried materials thus 
obtained were ground to fine powder and kept at room 
temperature in air-tight containers.
2.3. Animals
   Male Swiss albino mice weighing 20-25 g were used as 
test animals. The animals were housed in standard cages at 
room temperature under controlled light and temperature 
with free access to food and water. Prior to the experiments 
(about 24 h), the animals were maintained at the laboratory 
conditions with free access to water only. The animals 
submitted to oral administration of the test samples were 
fasted for 12 h.
2.4. In vivo analgesic activity studies
2.4.1. Writhing test
   The antinociceptive effect was evaluated by acetic acid 
induced writhing test in mice. The mouse writhing test 
was based on the previously described method of Koster 
et al[14,15]. The abdominal contortion or writhes resulting 
from intraperitoneal injection of 0.6% acetic acid consisted 
of a contraction of body muscles and the stretching of hind 
limb. These abdominal contortions were counted over three 
periods of 10 min each after injection of acetic acid. The 
antinociceptive activity was considered as the reduction 
of these abdominal contortions (writhes) in the treated 
animals (with test samples) as compared to control (injected 
only with acetic acid). The animals were pretreated orally 
with the test samples and aspirin (300 mg/kg of the body 
weight) was used as a standard during this test. The 
inhibition percent of the test samples was calculated by 
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using the following formula:
No. of  controlwrithing-No. of test groupwrithing
No. of controlwrithing
伊100Inhibition (%)=
2.4.2. Formalin test
   The antinociceptive effect was also evaluated by the 
formalin test in mice. About 2.5% formalin solution (0.04 
mL) was injected in the subplantar region of right hind 
paw of the mice to induce pain. Aspirin (36.2% inhibition 
in 1st phase and 29.6% in 2nd phase) was administered (30 
min before formalin injection) orally to serve as a positive 
control; whereas distilled water was used as a negative 
control. The test samples were administered orally (300 mg/
kg) 40 min before the reaction. The animals were placed 
in transparent plexiglas cage observation chambers and 
the time spent in licking and biting responses of the 
injected paw was taken as indicator of pain response[16,17]. 
Responses were measured for 5 min after formalin injection 
(early phase) and for 20-30 min after formalin injection 
(late phase). The reduction in the number of licking and 
biting responses is the inhibition of the pain score and the 
% inhibition can be calculated by the following expression:
Controlmean-Treatedmean
Controlmean
伊100Inhibition (%)=
   Where Controlmean is mean of control group; Treatedmean is 
mean of treated group.
2.5. Statistical analysis
   The statistical analyses were performed according to the 
method described by Al-Harrasi et al[18]. The values are 
expressed as mean依SEM. The significance of difference 
between means was determined by Student’s t-test at 
value of P<0.05.
3. Results
3.1. Extraction of oils and sub-fractionation of crude 
extract
   As a result of column chromatography, the methanol 
extract was fractionated into 36 fractions. On the basis 
of comparative thin layer chromatography (silica gel 60 
GF254) studies, seven sub-fractions (36%, 40%, 60%, 70% 
chloroform/n-hexane; and 2%, 4%, 6% methanol/chloroform) 
were selected for pharmacological evaluation along with 
the crude methanol extract. In addition to these, the 
essential oils were also extracted from the five grades (SHG, 
HR, RHW, HY, and SF) of frankincense resin.  
3.2. Analgesic activity studies
3.2.1. Writhing test
   The abdominal constrictions (writhes) in mice were 
induced by a 0.6% acetic acid solution, when administered 
orally. The resulting writhes were counted for three phases, 
within each 20 min period up to 60 min, as the writhing 
response may differ using various drugs[19]. Aspirin (300 
mg/kg) was used as positive control, and the inhibition of 
the acetic acid induced writhing was observed up to 67.6% 
in phase I, 66.8% in phase II, and 37.9% in phase III. The 
tested samples were also administered orally (300 mg/kg), 
and the notable differences were shown in the writhing 
frequency between the tested groups (P<0.05). All the 
tested samples showed significant inhibition of writhes as 
compared to the negative control (P<0.05), and the highest 
Table 1
Acetic acid induced writhing response and the inhibition by the tested samples.
Samples
Phase I (0 to 10 min) Phase II (10 to 20 min) Phase III (20 to 30 min)
No. of writhes Inhibition (%) No. of writhes Inhibition (%) No. of writhes Inhibition (%)
Control 56.00依2.08   0.0 64.00依2.98   0.0 13.00依0.92   0.0
SHG oil  32.00依1.09* 42.4 56.00依2.12 12.1   9.00依0.32 31.8
HR oil  35.00依1.56* 37.1 55.00依2.02 13.8   7.00依0.08 46.9
RHW oil 47.00依1.05 15.5 58.00依1.76   9.1  12.00依1.05   9.1
SF oil   21.00依1.07** 62.2   22.00依1.31** 65.5      6.00依0.32** 54.5
HY oil   26.00依1.22** 53.1  33.00依1.92* 48.3    9.00依0.22 31.8
Crude extract (HR)  37.00依1.37* 33.8  41.00依2.03* 35.3   10.00依0.83 22.7
36% chloroform/n-hexane  32.00依1.02
* 42.4  36.00依1.12* 43.6      8.00依0.92* 37.8
40% chloroform/n-hexane  33.00依2.09
* 42.4  43.00依2.37* 32.4   12.00依0.92 12.9
60% chloroform/n-hexane   22.00依1.42
** 60.4   30.00依1.33** 52.8      8.00依0.29* 39.4
70% chloroform/n-hexane   20.00依1.39
** 64.0  31.00依1.82* 51.4   10.00依0.89 24.2
2% MeOH/chloroform 39.00依2.01 29.7  44.00依2.05
*
30.7   11.00依1.02 16.7
4% MeOH/chloroform  38.00依1.39
* 31.3  43.00依1.86* 32.5   10.00依1.31 20.4
6% MeOH/chloroform 43.00依2.19 22.5 50.00依2.85 21.5   12.00依1.31   8.3
Aspirin   18.00依0.12** 67.6   21.00依0.45** 66.8      8.00依0.09* 37.9
Values are expressed as mean依SEM. Results evaluated at P<0.05 were considered significant, *: significant; **: highly significant in comparasion with control 
and standard drug aspirin.
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inhibition was observed by 70% chloroform/n-hexane sub-
fraction in phase I (64.0%), and by SF oil in phase II and III 
(65.5% and 54.5% respectively). However, the comparison 
with the positive control indicated that the highest 
inhibiting samples in phase I (64.0%) and II (65.5%) were just 
closer to the positive control (67.6% in phase I and 66.8% in 
phase II). Indeed, the SF oil sample in phase III inhibited 
the abdominal constrictions even more significantly (54.5%) 
as compared to the positive control (37.9%). The details of 
the percent inhibition of all the tested samples in phase I, 
II, and III are given in Table 1. 
3.2.2. Formalin test
   The results of formalin test are summarized in Table 
2. Our  tested samples (orally administered, 300 mg/kg) 
inhibited significantly the licking and biting response, 
induced by formalin in the biphasic pain response 
(the neurogenic pain response or the early phase and 
the inflammatory pain response or the late phase). 
When compared with the standard drug aspirin (orally 
administered, 300 mg/kg) with 36.2% inhibition in the early 
phase and 29.6% inhibition in the late phase, in most cases, 
our test samples showed more significant inhibition than 
the standard. As evident in Table 2, 10 out of 13 samples 
showed greater inhibition than the standard drug aspirin in 
the early phase and 9 out of 13 showed more inhibition in 
the late phase. The 60% and 70% chloroform/n-hexane sub-
fractions showed the highest inhibition (55.3% and 59.6% in 
early phase and 66.7% and 63.0% in late phase respectively) 
among the 10 samples, and this is far greater than the 
standard (36.2% in early phase and 29.6% in late phase). 
Table 2
Formalin induced licking and biting response and the inhibition by the tested 
samples.
Samples
Early phase (0 to 5 min) Late phase (20 to 30 min)
No. of licking 
and biting
Inhibition 
(%)
No. of licking 
and biting
Inhibition 
(%)
Control 47.00依2.08   0.0 27.00依2.98   0.0
SHG oil   28.00依1.09* 40.4  17.00依2.12* 37.0
HR oil 33.00依1.56 29.8 21.00依2.02 22.2
RHW oil 41.00依1.05 12.8 22.00依1.76 18.5
SF oil    20.00依1.07** 57.5   12.00依1.31** 55.6
HY oil   26.00依1.22* 44.7   13.00依1.92** 52.2
Crude extract   28.00依1.38* 40.4 19.00依1.04 29.6
36% chloroform/n-hexane   25.00依1.30
*
46.8  15.00依1.08* 44.5
40% chloroform/n-hexane   28.00依1.44
*
40.4  18.00依0.56* 33.3
60% chloroform/n-hexane    21.00依0.96
**
55.3     9.00依0.88** 66.7
70% chloroform/n-hexane    19.00依0.75
**
59.6   10.00依0.66** 63.0
2% MeOH/chloroform   31.00依2.01
*
34.1  17.00依1.95* 37.0
4% MeOH/chloroform   30.00依1.33
*
36.2  14.00依1.13* 48.2
6% MeOH/chloroform 33.00依1.09 29.8 22.00依1.08 18.5
Aspirin    30.00依0.12** 36.2 19.00依0.45 29.6
Values are expressed as mean依SEM. Results evaluated at P<0.05 were 
considered significant, *: significant; **: highly significant in comparasion 
with control and standard drug aspirin.
4. Discussion
   The crude methanol extract of the HR grade resin 
obtained from B. sacra was subjected to vacuum liquid 
chromatography by using a silica gel column. Several sub-
fractions were collected from the column when eluted with 
various polarity organic solvents in the order of increasing 
polarity. Based on the thin layer chromatography profiles, 
four fractions from the gradients of chloroform/n-hexane 
(36%, 40%, 60%, and 70% chloroform/n-hexane) and three 
fractions from the gradients of methanol/chloroform (2%, 
4%, and 6% methanol/chloroform) were selected for the 
analgesic studies. In addition, the crude methanol extract 
obtained by maceration, and the crude fats obtained 
through Soxhlet extraction by using n-hexane solvent 
were also investigated. Furthermore, the crude fats of 
the other grades (SHG, HR, RHW, SF, and HY) of the Omani 
frankincense were investigated for the comparative 
studies.
   In the present study, the antinociception test was 
selected in such a way that both the centrally and 
peripherally mediated effects of all the samples were 
investigated. The writhing (acetic acid induced abdominal 
constriction) test was used for the peripheral activity[20-
22], whereas both the central and the peripheral mediated 
effects were investigated by the formalin test. The acetic 
acid induced writhing test is more sensitive and can 
produce various grades of noxious stimuli in tissue 
damage[23]. The injection of acetic acid is also associated 
with increased level of sympathomimetic system mediators 
(PGE2 and PGF2), prostaglandins[24], protanoids, and 
lipoxygenase products[25] in the peritoneal fluid and the 
abdominal contortions induced by acetic acid are thought 
to involve local peritoneal receptors and mediated by 
prostaglandin pathways[22,26,27]. The present study revealed 
that the test samples showed a significant inhibition of the 
acetic acid induced writhes and some of the test samples 
(SF oil and 60% and 70% sub-fractions) even showed 
approximately the same inhibitory potential to that of the 
standard drug aspirin (67.6% inhibition in phase I, 66.8% 
in phase II and 37.9% in phase III). The crude extract and 
the oil from HR resin showed the reduction of writhes 
up to approximately 50% when compared to the positive 
control, whereas the comparison with the negative control 
showed approximately 35% inhibition in the writhing 
test. In addition, HY and SHG oils and the low polar sub-
fractions (36% and 40%) showed more than 40% inhibition 
when compared to the negative control, and more than 
60% when compared to the positive control (aspirin). The 
polar sub-fractions (2%, 4%, 6% methanol/chloroform) and 
RHW oil showed moderate to less inhibition in the writhing 
Ahmed Al-Harrasi et al./Asian Pac J Trop Med 2014; 7(Suppl 1): S485-S490 S489
test. Thus on the basis of these results, it is evident that 
the sub-fractions of the crude extract obtained at medium 
polarity (40%-80% chloroform/n-hexane) were effective in 
reduction of writhes when compared to both the positive 
and the negative controls. As the writhing is related to the 
increase in levels of leukotrienes and prostaglandins[24], 
our medium polarity samples are likely to follow the 
mechanism of lipoxygenase and cycloxygenase.
   Although the acetic acid induced abdominal writhing 
test is recognized as a useful measure for the evaluation 
of analgesia, this is not a specific model, since several 
compounds inhibit the writhes induced by acetic acid 
and this test has poor specificity[28-30]. Even some central 
nervous system depressant type of the non-analgesic 
compounds showed positive response in the acetic acid 
induced abdominal writhing test[31]. To overcome the 
situation, the abdominal writhes were counted for three 
consecutive phases of 20 min each and then the percent 
inhibition is calculated for each individual phase. 
Furthermore, the formalin test was conducted on all the 
test samples to confirm and support the possible analgesic 
mechanism for the tested samples.
   The formalin test  is  a more reliable model of 
nociception which investigates the possible mechanism 
of antinociceptive action of the analgesic drugs. The 
biphasic behavior seems to be associated with two distinct 
mechanisms. The first phase is the early neurogenic pain 
phase which is the result of direct stimulation by formalin. 
It starts immediately after the formalin solution has been 
injected and lasts for 5-10 min. The second phase is the 
inflammatory pain late phase which is believed to have 
arose from the spinal neuron hyperactivity involving 
various mediators[32,33]. The results of the formalin test 
indicated that our tested samples showed significant 
antinociceptive effects in both the early and the late 
phases. This inhibition in both the early and the late 
phases of formalin induced pain test indicated the 
contribution of both mechanisms in the overall analgesic 
effect. The samples of SF oil and the 60% and 70% 
chloroform sub-fractions showed the significant reduction 
in the pain score in early phase which was even higher 
than that of the standard drug (aspirin, 29.6% inhibition) 
used in the study. Furthermore, in the later phase the 
samples of 60% and 70% chloroform sub-fractions showed 
potent inhibition (66.7% and 63.0% respectively), which 
was two field higher when compared to the positive 
control (aspirin, 29.6% inhibition). The polar sub-fractions 
(2%, 4%, 6% methanol) showed moderate inhibition (34.1%, 
36.2%, and 29.8% respectively) in the early phase; however 
2% and 4% sub-fractions significantly reduced (37.0% and 
48.2% respectively) the pain score in the late phase of the 
formalin test. This indicated that the polar sub-fractions 
have more anti-inflammatory potential than the analgesic, 
whereas the medium polarity sub-fractions possessed the 
analgesic as well as the anti-inflammatory potential.
   Due to lack of the mice death, the LD50 value could 
not be measured at even high concentration of the test 
samples (300 mg/kg of the body weight). At the same time, 
these results indicated that the various grades of resin 
obtained from B. sacra has comparatively lower toxicity 
profile[34]. 
   The results of the antinociception in writhing test and 
in formalin test on the one hand suggested the central 
and the peripheral action of the samples, and on the other 
hand indicated the possibility of the anti-inflammatory 
activity of the samples, more specifically expected in the 
polar sub-fractions (2% and 4% methanol). In some cases, 
our tested samples are indicated to have almost double 
inhibitory potential than that of the standard drug used in 
the study. Thus the present study provokes and validates 
the traditional use of the Omani traditional frankincense 
for muscle, stomach, and arthritis pain.
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